-
MACRILEN™(macimorelin)
•Filing of a New Drug Application ("NDA") seeking approval for the commercialization of MACRILEN™ as the firstavailable oral product indicated for the evaluation of Adult Growth Hormone Deficiency
. NDA currently undersubstantive review by the US Food and Drug
Administration with a Prescription Drug User Fee Act date of November 5,2014
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
Forum Rules